La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Titre (en) » - entrée « action »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
acting < action < actionability  Facettes :

List of bibliographic references indexed by action

Number of relevant bibliographic references: 31.
[0-20] [0 - 20][0 - 31][20-30][20-40]
Ident.Authors (with country if any)Title
000213 (2016) Abdul Qayyum Rana ; Mohamad SalehRelationship between resting and action tremors in Parkinson's disease
000527 (2015) Fariborz Rahimi [Canada] ; Carina Bee [Irlande (pays)] ; David Wang [Canada] ; Farrokh Janabi-Sharifi [Canada] ; Quincy J. Almeida [Canada]Subgroup analysis of PD tremor with loading: action tremor as a combination of classical rest and physiological tremor.
000843 (2015) Dany Arsenault [Canada] ; Janelle Drouin-Ouellet [Royaume-Uni] ; Martine Saint-Pierre [Canada] ; Petros Petrou [Canada] ; Marilyn Dubois [Canada] ; Jasna Kriz [Canada] ; Roger A. Barker [Royaume-Uni] ; Antonio Cicchetti [Canada] ; Francesca Cicchetti [Canada]A novel combinational approach of microstimulation and bioluminescence imaging to study the mechanisms of action of cerebral electrical stimulation in mice
000846 (2015) Lina A. Matschke [Allemagne] ; Mirjam Bertoune [Allemagne] ; Jochen Roeper [Allemagne] ; Terrance P. Snutch [Canada] ; Wolfgang H. Oertel [Allemagne] ; Susanne Rinné [Allemagne] ; Niels Decher [Allemagne]A concerted action of L- and T-type Ca(2+) channels regulates locus coeruleus pacemaking.
000877 (2014) Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Katie D. Lewis [Australie] ; James B. Koprich [Canada] ; M Gabriela Reyes [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Jonathan M. Brotchie [Canada]UWA-121, a mixed dopamine and serotonin re-uptake inhibitor, enhances L-DOPA anti-parkinsonian action without worsening dyskinesia or psychosis-like behaviours in the MPTP-lesioned common marmoset.
000A39 (2014) Payam Piray [Pays-Bas] ; Yashar Zeighami [Canada] ; Fariba Bahrami [Iran] ; Abeer M. Eissa ; Doaa H. Hewedi ; Ahmed A. Moustafa [Pays-Bas]Impulse control disorders in Parkinson's disease are associated with dysfunction in stimulus valuation but not action valuation.
000A62 (2014) Atsuko Nagano-Saito [Canada] ; Kristina Martinu [Canada] ; Oury Monchi [Canada]Function of basal ganglia in bridging cognitive and motor modules to perform an action
000B14 (2014) Jean-Francois Esculier [Canada] ; Joanie Vaudrin [Canada] ; Louis E. Tremblay [Canada]Corticomotor excitability in Parkinson's disease during observation, imagery and imitation of action: effects of rehabilitation using wii fit and comparison to healthy controls.
000B58 (2014) Pieter-Jan Maes [Canada] ; Marc Leman [Belgique] ; Caroline Palmer [Canada] ; Marcelo M. Wanderley [Canada]Action-based effects on music perception
000F94 (2013) B. Swinburn [Nouvelle-Zélande, Australie] ; G. Sacks [Australie] ; S. Vandevijvere [Nouvelle-Zélande] ; S. Kumanyika [États-Unis] ; T. Lobstein [Royaume-Uni, Australie] ; B. Neal [Australie] ; S. Barquera [Mexique] ; S. Friel [Australie] ; C. Hawkes [Royaume-Uni] ; B. Kelly [Australie] ; M. L'Abbé [Canada] ; A. Lee [Australie] ; J. Ma [République populaire de Chine] ; J. Macmullan [Royaume-Uni] ; S. Mohan [Inde] ; C. Monteiro [Brésil] ; M. Rayner [Royaume-Uni] ; D. Sanders [Afrique du Sud] ; W. Snowdon [Australie, Fidji] ; C. Walker [Suisse]INFORMAS (International Network for Food and Obesity/non‐communicable diseases Research, Monitoring and Action Support): overview and key principles
001459 (2012) Terence K. Y. Lai [Canada] ; Philip Seeman [Canada] ; Fang Liu [Canada]Cell membrane lytic action of metoclopramide and its relation to tardive dyskinesia
001773 (2011) Andrea B. Dann [Canada] ; Alice Hontela [Canada]Triclosan: environmental exposure, toxicity and mechanisms of action
001778 (2011) James B. Koprich [Canada] ; Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; Allan Goodman [États-Unis] ; Bertrand Le Bourdonnec [États-Unis] ; Roland E. Dolle [États-Unis] ; Robert N. Dehaven [États-Unis] ; Diane L. Dehaven-Hudkins [États-Unis] ; Patrick J. Little [États-Unis] ; Jonathan M. Brotchie [Canada]The selective mu‐opioid receptor antagonist adl5510 reduces levodopa‐induced dyskinesia without affecting antiparkinsonian action in mptp‐lesioned macaque model of Parkinson's disease
001B51 (2010) Tom H. Johnston [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Juha-Matti Savola [Suisse] ; Jonathan M. Brotchie [Canada]The α2 adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates
001D46 (2009) Xiaoqian Liu [États-Unis] ; Travis Rush ; Jasmine Zapata ; Doug Lobnerbeta-N-methylamino-l-alanine induces oxidative stress and glutamate release through action on system Xc(-).
002079 (2009) M. Bousquet [Canada] ; C. Gibrat [Canada] ; M. Saint-Pierre [Canada] ; C. Julien [Canada] ; F. Calon [Canada] ; F. Cicchetti [Canada]Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model
002305 (2008) Philip Seeman [Canada] ; Carla Caruso [Argentine] ; Mercedes Lasaga [Argentine]Memantine agonist action at dopamine D2High receptors
002661 (2007) Frédéric Calon [Canada] ; Greg Cole [États-Unis]Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases : Evidence from animal studies
002823 (2006) H. Bazzazi [Canada] ; R. B. Clark [Canada] ; W. R. Giles [États-Unis]Mathematical Simulations of the Effects of Altered AMP‐Kinase Activity on INa and the Action Potential in Rat Ventricle
002A21 (2005) J S Sloka [Canada] ; M. Stefanelli [Canada]The mechanism of action of methylprednisolone in the treatment of multiple sclerosis
002B14 (2005) Shawn Hayley [Canada] ; Hymie Anisman [Canada]Multiple mechanisms of cytokine action in neurodegenerative and psychiatric states: Neurochemical and molecular substrates : The role of cytokines in neurodegeneration and psychiatric conditions: Multiple mechanisms of action

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "action" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "action" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    action
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022